WF
Insider
W. Michael Flanagan
Chief Scientific OfficerW. Michael Flanagan (Chief Scientific Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in RNA. The largest single filing was $473K of RNA (6,534 sh across 2 lots, as filed), executed Jan 21.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$645K
shares × price, as filed
Last traded
Jan 21
Filed Jan 23
Volume by month
Buys $0
Sells $7.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
2 filings
Sector per market data · by filing · past 12 months
Most traded names
RNA
RNA
RNA · 0 buys · 11 sells
11 filings
Recent filings
RNASALE
Avidity Biosciences, Inc.
View filing →
$473K6,534 sh across 2 lots
Exec Jan 21
Filed Jan 23 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $171K
2,373 sh × $72.23
Exec Jan 7
Filed Jan 9 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $779K
20,000 sh × $38.94
Exec Sep 11 2025
Filed Sep 12 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $658K
20,000 sh × $32.88
Exec Jun 11 2025
Filed Jun 12 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $366K
11,780 sh × $31.06
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $603K
20,000 sh × $30.13
Exec Mar 11 2025
Filed Mar 12 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $110K
3,860 sh × $28.60
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $416K
12,742 sh × $32.66
Exec Dec 18 2024
Filed Dec 19 2024 · 5:30 PM ET More filings →